| Secondary |
| Parenteral Nutrition |
31.8% |
| Drug Use For Unknown Indication |
17.9% |
| Product Used For Unknown Indication |
9.9% |
| Hypertension |
8.6% |
| Total Parenteral Nutrition |
6.0% |
| Atrial Fibrillation |
5.3% |
| Intentional Overdose |
2.6% |
| Pain |
2.6% |
| Premedication |
2.6% |
| Blood Cholesterol Increased |
2.0% |
| Blood Potassium Decreased |
1.3% |
| Burning Sensation |
1.3% |
| Diabetes Mellitus |
1.3% |
| Diabetes Mellitus Non-insulin-dependent |
1.3% |
| Prophylaxis |
1.3% |
| Sleep Disorder |
1.3% |
| Anticoagulant Therapy |
0.7% |
| Anxiety |
0.7% |
| Breakthrough Pain |
0.7% |
| Chronic Lymphocytic Leukaemia |
0.7% |
|
| Product Compounding Quality Issue |
8.0% |
| Ultrasound Abdomen Abnormal |
8.0% |
| Upper Gastrointestinal Haemorrhage |
8.0% |
| Ventricular Fibrillation |
8.0% |
| Vomiting |
8.0% |
| Depression |
4.0% |
| Dizziness |
4.0% |
| Drug Ineffective |
4.0% |
| Hypotension |
4.0% |
| Incorrect Dose Administered |
4.0% |
| Intentional Overdose |
4.0% |
| Multiple Drug Overdose |
4.0% |
| Nausea |
4.0% |
| Overdose |
4.0% |
| Product Colour Issue |
4.0% |
| Pyrexia |
4.0% |
| Suicide Attempt |
4.0% |
| Unevaluable Event |
4.0% |
| Ventricular Tachycardia |
4.0% |
| Weight Decreased |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.1% |
| Drug Use For Unknown Indication |
15.7% |
| Hypertension |
8.5% |
| Pain |
4.8% |
| Diabetes Mellitus |
3.6% |
| Multiple Myeloma |
3.6% |
| Rheumatoid Arthritis |
3.4% |
| Depression |
3.3% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Asthma |
3.0% |
| Blood Cholesterol Increased |
2.8% |
| Diabetes Mellitus Non-insulin-dependent |
2.6% |
| Osteoporosis |
2.6% |
| Anxiety |
2.3% |
| Atrial Fibrillation |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Supplementation Therapy |
2.2% |
| Cardiac Disorder |
1.8% |
| Prophylaxis |
1.8% |
| Mineral Supplementation |
1.5% |
|
| Weight Decreased |
10.9% |
| Weight Increased |
9.7% |
| Vomiting |
7.6% |
| Death |
5.7% |
| Drug Ineffective |
5.7% |
| White Blood Cell Count Decreased |
5.1% |
| Tremor |
4.5% |
| Vision Blurred |
4.5% |
| Visual Acuity Reduced |
4.5% |
| Dyspnoea |
4.2% |
| Myocardial Infarction |
4.2% |
| Nausea |
4.2% |
| Pain In Extremity |
4.2% |
| Syncope |
4.2% |
| Pharmaceutical Product Complaint |
3.9% |
| Pneumonia |
3.6% |
| Somnolence |
3.6% |
| Rash |
3.3% |
| Renal Failure Acute |
3.0% |
| Urinary Tract Infection |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Drug Interaction |
50.0% |
| Hyperkalaemia |
50.0% |
|
